Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Shares outstanding
-
17,264,276
-
Total 13F shares
-
15,028,755
-
Share change
-
+14,943,755
-
Total reported value
-
$150,646,354
-
Price per share
-
$10.02
-
Number of holders
-
42
-
Value change
-
+$149,794,654
-
Number of buys
-
41
Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q4 2024
As of 31 Dec 2024,
Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,028,755 shares.
The largest 10 holders included
AQR Arbitrage LLC, Magnetar Financial LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, LMR Partners LLP, Polar Asset Management Partners Inc., K2 PRINCIPAL FUND, L.P., Hudson Bay Capital Management LP, First Trust Capital Management L.P., TENOR CAPITAL MANAGEMENT Co., L.P., and Linden Advisors LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.